Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - Springer
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …
被引用次数：40 相关文章

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - infona.pl
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

K Charalampos, A Stavros, E Lars… - …, 2013 - cris.unibo.it
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

[引用][C] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C Kasmeridis, S Apostolakis, LH Ehlers… - …, 2013 - vbn.aau.dk
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel
Oral Anticoagulants — Aalborg University's Research Portal Skip to main navigation Skip to …

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants.

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - europepmc.org
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - search.proquest.com
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - econpapers.repec.org
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

[引用][C] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C KASMERIDIS, S APOSTOLAKIS… - …, 2013 - pascal-francis.inist.fr
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the
Novel Oral Anticoagulants CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Cost effectiveness of treatments for stroke prevention in atrial fibrillation: focus on the novel oral anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - pubmed.ncbi.nlm.nih.gov
For more than 5 decades, the only available treatment for the prevention of atrial fibrillation
(AF)-related stroke were the vitamin K antagonists. Recently, novel oral anticoagulants …

[引用][C] Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

C Kasmeridis, S Apostolakis, L Ehlers… - …, 2013 - cir.nii.ac.jp
Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the
Novel Oral Anticoagulants | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …